PHA Welcomes New Officers, Board Members
Meet PHA’s new Board of Trustees officers and members serving in leadership roles starting July 1.
News
In the News
Discover the latest news from the Pulmonary Hypertension, including advocacy updates, research articles and event coverage.
Recent news
Dislaying 25 — 30 of 405
-
-
Meet Our Kitchen Table Society AwardeesCelebrate PHA’s 2026 Kitchen Table Society Award winners, honored for their support, trust and commitment to PHA’s mission.
Events | News
-
PHA 2026: Connecting the Community from Across Town and Around the GlobePHA 2026 International PH Conference draws 1,000 global attendees to learn, connect, and celebrate PH advancements—see highlights and photos.
Events
-
9 Volunteers Who Go the Extra MilePHA honored nine dedicated members of the PH community during a ceremony at the PHA 2026 International PH Conference and Scientific Sessions in Dallas.
Events | News
-
How PHA Conferences Benefit the PH CommunityPHA 2026 delivers support, information, and hope—advancing care to enhance and extend lives affected by pulmonary hypertension, even beyond the conference.
News
-
Speak Out for Oxygen AccessUrge Congress to support the SOAR Act by joining our June advocacy challenge.
Get involved
PH in the News
-
Liquidia and United Therapeutics Announce Global Settlement Resolving All Pending Litigation
The settlement follows a September 2026 federal court ruling in favor of United Therapeutics regarding two patent infringement claims related to the use of inhaled treprostinil for PH-ILD. No safety concerns were raised.
-
FDA OKs sotatercept label update
The label references trial data that shows the drug as safe and effective for moderate to high-risk PAH.
-
Pulmovant opens Phase 3 mosliciguat study
Pulmovant is enrolling participants in its Phase 3 mosliciguat study after positive Phase 2 results.